Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Investor Update directly as they happen.
Follow now 320 followers
Last updated 1 day ago
1 day ago
New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel...
4 days ago
We are pleased to invite investors and analysts to participate in our...
9 days ago
Group sales grew by 6%1 at constant exchange rates (CER) (2% in...
16 days ago
Roche will publish its Sales for the 3rd Quarter of 2024 prior...
18 days ago
Positive data confirm Evrysdi efficacy and safety in children first treated pre-symptomatically...
21 days ago
Basel, 11 October 2024 - Roche announced today its submission of greenhouse...
21 days ago
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based...
24 days ago
We are pleased to invite investors and analysts to participate in our...
about 1 month ago
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy...
about 1 month ago
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets...
about 1 month ago
Roche will publish its Sales for the 3rd Quarter of 2024 prior...
about 1 month ago
The Roche Investor Relations team would like to invite you to the...